BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26464236)

  • 1. Quantifying the impact of time-varying baseline risk adjustment in the self-controlled risk interval design.
    Li L; Kulldorff M; Russek-Cohen E; Kawai AT; Hua W
    Pharmacoepidemiol Drug Saf; 2015 Dec; 24(12):1304-12. PubMed ID: 26464236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional polynomial adjustment for time-varying covariates in a self-controlled case series analysis.
    Lee KJ; Carlin JB
    Stat Med; 2014 Jan; 33(1):105-16. PubMed ID: 23868284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new self-controlled case series method for analyzing spontaneous reports of adverse events after vaccination.
    Escolano S; Hill C; Tubert-Bitter P
    Am J Epidemiol; 2013 Nov; 178(9):1496-504. PubMed ID: 24013203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of short-term exposure to air pollution on hospital admissions of young children for acute lower respiratory infections in Ho Chi Minh City, Vietnam.
    ; Le TG; Ngo L; Mehta S; Do VD; Thach TQ; Vu XD; Nguyen DT; Cohen A
    Res Rep Health Eff Inst; 2012 Jun; (169):5-72; discussion 73-83. PubMed ID: 22849236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intussusception risk after RotaTeq vaccination: evaluation from worldwide spontaneous reporting data using a self-controlled case series approach.
    Escolano S; Hill C; Tubert-Bitter P
    Vaccine; 2015 Feb; 33(8):1017-20. PubMed ID: 25596460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple self-controlled case series for large-scale longitudinal observational databases.
    Simpson SE; Madigan D; Zorych I; Schuemie MJ; Ryan PB; Suchard MA
    Biometrics; 2013 Dec; 69(4):893-902. PubMed ID: 24117144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadening the age restriction for initiating rotavirus vaccination in regions with high rotavirus mortality: benefits of mortality reduction versus risk of fatal intussusception.
    Patel MM; Clark AD; Glass RI; Greenberg H; Tate J; Santosham M; Sanderson CF; Steele D; Cortese M; Parashar UD
    Vaccine; 2009 May; 27(22):2916-22. PubMed ID: 19428901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for time-varying exposure related problems in pharmacoepidemiology: An overview.
    Pazzagli L; Linder M; Zhang M; Vago E; Stang P; Myers D; Andersen M; Bahmanyar S
    Pharmacoepidemiol Drug Saf; 2018 Feb; 27(2):148-160. PubMed ID: 29285840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intussusception following rotavirus vaccination in the Valencia Region, Spain.
    Pérez-Vilar S; Díez-Domingo J; Puig-Barberà J; Gil-Prieto R; Romio S
    Hum Vaccin Immunother; 2015; 11(7):1848-52. PubMed ID: 26083707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Intussusception Risk after Pentavalent Rotavirus Vaccination in Finnish Infants.
    Leino T; Ollgren J; Strömberg N; Elonsalo U
    PLoS One; 2016; 11(3):e0144812. PubMed ID: 26950702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of post-licensure data on benefits and risks of vaccination to inform vaccine policy: The example of rotavirus vaccines.
    Parashar UD; Cortese MM; Payne DC; Lopman B; Yen C; Tate JE
    Vaccine; 2015 Nov; 33 Suppl 4():D55-9. PubMed ID: 26122581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Post-licensure passive safety surveillance of rotavirus vaccines: reporting sensitivity for intussusception].
    Pérez-Vilar S; Díez-Domingo J; Gomar-Fayos J; Pastor-Villalba E; Sastre-Cantón M; Puig-Barberà J
    An Pediatr (Barc); 2014 Aug; 81(2):77-85. PubMed ID: 24252603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the 1990 Hong Kong legislation for restriction on sulfur content in fuel.
    Wong CM; Rabl A; Thach TQ; Chau YK; Chan KP; Cowling BJ; Lai HK; Lam TH; McGhee SM; Anderson HR; Hedley AJ
    Res Rep Health Eff Inst; 2012 Aug; (170):5-91. PubMed ID: 23316618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus vaccination and intussusception: can we decrease temporally associated background cases of intussusception by restricting the vaccination schedule?
    Tai JH; Curns AT; Parashar UD; Bresee JS; Glass RI
    Pediatrics; 2006 Aug; 118(2):e258-64. PubMed ID: 16882770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Meta-analysis of the Italian studies on short-term effects of air pollution].
    Biggeri A; Bellini P; Terracini B;
    Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of prior event rate ratio adjustment method in pharmacoepidemiology: a simulation study.
    Uddin MJ; Groenwold RH; van Staa TP; de Boer A; Belitser SV; Hoes AW; Roes KC; Klungel OH
    Pharmacoepidemiol Drug Saf; 2015 May; 24(5):468-77. PubMed ID: 25410590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of postlicensure safety of rotavirus vaccines, with emphasis on intussusception.
    Bines JE; Patel M; Parashar U
    J Infect Dis; 2009 Nov; 200 Suppl 1():S282-90. PubMed ID: 19817611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.
    Shui IM; Baggs J; Patel M; Parashar UD; Rett M; Belongia EA; Hambidge SJ; Glanz JM; Klein NP; Weintraub E
    JAMA; 2012 Feb; 307(6):598-604. PubMed ID: 22318281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.
    John J; Kawade A; Rongsen-Chandola T; Bavdekar A; Bhandari N; Taneja S; Antony K; Bhatnagar V; Gupta A; Kabra M; Kang G
    Vaccine; 2014 Aug; 32 Suppl 1():A104-9. PubMed ID: 25091662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.